FDA Panel Backs Remicade for Kids With Ulcerative Colitis

(MedPage Today) — SILVER SPRING, Md. — An FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children.

Post a Comment

Comments are closed.